Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Witzel

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neurology|July 25, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseasesSteffen Halbgebauer, Veronika Klose, Badrieh Fazeli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 14, 2020
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosisJohannes Dorst, Joachim Schuster, Jens Dreyhaupt, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
JAMA Neurology|January 10, 2022
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral SclerosisSimon Witzel, André Maier, Robert Steinbach, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
European Journal of Neurology|April 4, 2025
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?Johannes Dorst, Jens Dreyhaupt, Deborah Wernecke, et al.
Annals of Neurology|August 23, 2024
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral SclerosisSimon Witzel, André Huss, Gabriele Nagel, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Journal of Neurology|March 8, 2025
Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Journal of Neurology|August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neurology|July 25, 2025
Neurofilament light chain reference values in serum and cerebrospinal fluid: a bi-compartmental analysis in neurological diseasesSteffen Halbgebauer, Veronika Klose, Badrieh Fazeli, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|August 14, 2020
Effect of high-caloric nutrition on serum neurofilament light chain levels in amyotrophic lateral sclerosisJohannes Dorst, Joachim Schuster, Jens Dreyhaupt, et al.
Ebiomedicine|March 14, 2023
Metabolic alterations precede neurofilament changes in presymptomatic ALS gene carriersJohannes Dorst, Patrick Weydt, David Brenner, et al.
JAMA Neurology|January 10, 2022
Safety and Effectiveness of Long-term Intravenous Administration of Edaravone for Treatment of Patients With Amyotrophic Lateral SclerosisSimon Witzel, André Maier, Robert Steinbach, et al.
European Journal of Neurology|January 19, 2024
In-depth analysis of data from the RAS-ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosisJoachim Schuster, Jens Dreyhaupt, Karla Mönkemöller, et al.
European Journal of Neurology|April 4, 2025
Population-Based Versus Hospital-Based Data in Amyotrophic Lateral Sclerosis-A Factor to Consider?Johannes Dorst, Jens Dreyhaupt, Deborah Wernecke, et al.
Annals of Neurology|August 23, 2024
Population-Based Evidence for the Use of Serum Neurofilaments as Individual Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral SclerosisSimon Witzel, André Huss, Gabriele Nagel, et al.
Brain Communications|April 3, 2023
Clinical and genetic features of amyotrophic lateral sclerosis patients with <i>C9orf72</i> mutationsMaximilian Wiesenfarth, Kornelia Günther, Kathrin Müller, et al.
Journal of Neurology|March 8, 2025
Correction: Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Journal of Neurology|August 14, 2024
Clinical characterization of common pathogenic variants of SOD1-ALS in GermanyMaximilian Wiesenfarth, Yalda Forouhideh-Wiesenfarth, Zeynep Elmas, et al.
Pageof 4